PACAP has also been shown to have anti-inflammatory effects in the CNS (Waschek 2013), while VIP inhibits inflammation in a wide range of neurodegenerative disorders, including Alzheimer’s, Parkinson’s (PD), and Huntington’s diseases (Deng and Jin 2017). Here, VIP is linked to Parkinson disease.